Revenues of BIO-TECHNE Corp from 30 Jun 2023 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary: BIO-TECHNE Corp quarterly and annual Revenues in USD history and change rate from 30 Jun 2023 to 31 Dec 2025.
BIO-TECHNE Corp Revenues for the quarter ending 31 Dec 2025 was $295,877,000, a 0.39% decline year-over-year.
BIO-TECHNE Corp annual Revenues for 2025 was $1,219,635,000, a 5.2% increase from 2024.
BIO-TECHNE Corp annual Revenues for 2024 was $1,159,060,000, a 2% increase from 2023.
Source SEC data: View on sec.gov

Revenues, Quarterly (USD)

Revenues, YoY Quarterly Change (%)

Revenues, Annual (USD)

Revenues, YoY Annual Change (%)

BIO-TECHNE Corp Quarterly Revenues (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$295,877,000	-$1,154,000	-0.39%	01 Oct 2025	31 Dec 2025	10-Q	04 Feb 2026	2026	Q2
Q3 2025	$286,555,000	-$2,903,000	-1%	01 Jul 2025	30 Sep 2025	10-Q	05 Nov 2025	2026	Q1
Q4 2024	$297,031,000			01 Oct 2024	31 Dec 2024	10-Q	04 Feb 2026	2026	Q2
Q3 2024	$289,458,000			01 Jul 2024	30 Sep 2024	10-Q	05 Nov 2025	2026	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2025	$1,219,635,000	+$60,575,000	+5.2%	01 Jul 2024	30 Jun 2025	10-K	22 Aug 2025	2025	FY
2024	$1,159,060,000	+$22,358,000	+2%	01 Jul 2023	30 Jun 2024	10-K	22 Aug 2025	2025	FY
2023	$1,136,702,000			01 Jul 2022	30 Jun 2023	10-K	22 Aug 2025	2025	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.